First Capital Partner plans to significantly increase its stake in $PAT (+0,56 %) significantly. Through a public partial tender offer at 8.20 euros per share, the stake is to be increased to up to 73% of the share capital. First Capital currently holds approximately 58.89% of Patrizia’s share capital. First Capital is backed by Patrizia founder Wolfgang Egger. A downlisting agreement was also signed in conjunction with this offer. In the future, Patrizia shares will no longer be listed on the regulated market (Prime Standard) but rather in the Scale over-the-counter segment of the Frankfurt Stock Exchange. Patrizia’s managing director and board of directors have approved the conclusion of the agreement.
Patrizia
Price
Discussion sur PAT
Postes
4Patrizia: Higher Profits Despite a Decline in Assets Under Management
The investment manager $PAT (+0,56 %) increased its operating profit (EBITDA) by 37.3% year-over-year to 61.3 million euros in the first nine months. Net income for the period nearly tripled to 20.5 million euros (previous year: 6.9 million euros). This increase was driven by the ongoing cost-cutting measures and improved operational efficiency. There was also a sharp rise in equity raised (+57% to 1.2 billion euros). Transaction volume grew by just under 12% to 2.6 billion euros, driven primarily by higher sales. The full-year earnings forecast was revised upward. EBITDA is expected to range between 65 and 75 million euros (previously: 60 to 75 million euros). Assets under management, however, are expected to decline to 53 to 57 billion euros (previously: 55 to 60 billion euros).
PATRIZIA maintains profit target despite balance sheet changes
Have you heard about the latest developments at PATRIZIA $PAT (+0,56 %) heard? The real estate asset manager has postponed its annual report due to a need to amend the 2022 and 2023 balance sheets. But don't worry, the profit target for 2024 remains unchanged! 👍
The company expects earnings before interest, taxes, depreciation and amortization (EBITDA) to be in the middle of the forecast range between 30 and 60 million euros. The adjustments to the balance sheets will only have a minimal impact on the key financial figures for the coming year and will not affect the operating business or liquidity.
The adjustments are due to the Whitehelm acquisition in 2022, for which contingent purchase price payments were agreed. These are now recognized as personnel expenses, which will lead to an increase in personnel expenses in the years 2022 to 2024.
The publication of the business figures for 2024 has been postponed to March 24. Stay tuned to see how this will affect the PATRIZIA share!
Analyst updates, 28.11.
⬆️⬆️⬆️
- HAUCK AUFHÄUSER IB raises the price target for ECKERT & ZIEGLER from EUR 55 to EUR 56.50. Buy. $EUZ (-2,73 %)
- EXANE BNP raises the target price for FREENET from EUR 30 to EUR 34. Outperform. $FNTN (+2,26 %)
- HAUCK AUFHÄUSER IB raises the price target for NORTHERN DATA from EUR 45 to EUR 52. Buy. $NB2 (-3,29 %)
- WARBURG RESEARCH raises the price target for PATRIZIA from EUR 9.80 to EUR 9.90. Buy. $PAT (+0,56 %)
- DEUTSCHE BANK RESEARCH raises the price target for EASYJET from GBP 6.70 to GBP 7.15. Buy. $EZJ (-0,74 %)
- EXANE BNP upgrades TRATON to Outperform. Target price EUR 35. $8TRA (-2,88 %)
- JPMORGAN raises the price target for CTS EVENTIM from EUR 101 to EUR 104. Overweight. $EVD (+1,37 %)
⬇️⬇️⬇️
- BRYAN GARNIER lowers the price target for LVMH from EUR 800 to EUR 770. Buy. $MC (-2,08 %)
- KEPLER CHEUVREUX lowers the price target for PORSCHE SE from EUR 48 to EUR 47. Buy. $PAH3 (-3,08 %)
- DEUTSCHE BANK RESEARCH lowers the price target for SYMRISE from EUR 130 to EUR 125. Buy. $SY1 (-1,43 %)
- WARBURG RESEARCH lowers the price target for ABO ENERGY from EUR 114 to EUR 110. Buy. $AB9 (-4,26 %)
- EXANE BNP lowers the target price for 1&1 from EUR 15 to EUR 12. Neutral. $1U1 (+0,41 %)
- EXANE BNP lowers the price target for UNITED INTERNET from EUR 20 to EUR 17. Neutral. $UTDI (-0,95 %)
- STIFEL downgrades COMPUGROUP from Buy to Hold and lowers target price from EUR 64 to EUR 18. $COP (+0,46 %)
- BARCLAYS lowers the price target for SCHOTT PHARMA from EUR 33 to EUR 27. Equal-Weight. $1SXP (-3,33 %)
- UBS lowers the price target for VESTAS from DKK 245 to DKK 175. Buy. $VWS (-3,73 %)
Titres populaires
Meilleurs créateurs cette semaine